Cell Reports MethodsCell BiologyPeer-reviewed journal article
Xeno-free human iPSC-derived prostate organoid platform for multilineage differentiation and genetic manipulation
Neha Shaikh, Matthew D. TeasdaleiD, Lewis J. Walker, Laura WilsoniD, Rachel Howarth, Sara Saleem, Jamie Logsdon, Anastasia C. HepburniD, Ryan NelsoniD, Qiuyu LianiD, Aleyda C. Elizondo, Rafiqul HussainiD, Jonathan M CoxheadiD, Luke GaughaniD, Majlinda LakoiD, Emma ScottiD, Craig N. RobsoniD, Benjamin D. SimonsiD, Simon W. HaywardiD, Douglas W. StrandiD, Rakesh HeeriD, Adriana BuskiniD
Abstract
Current prostate organoid models rely on tissue-derived material or animal components and lack epithelial and stromal complexity. We defined a xeno-free system to generate human prostate organoids from induced pluripotent stem cells with consistent multilineage differentiation. Floating organoids self-organize into epithelial and stromal domains with basal, luminal, neuroendocrine, fibroblast, and smooth muscle markers. In an alternative modular co-culture system, engineered epithelial progenitors are aggregated with wild-type mesenchymal progenitors, enabling compartment-specific manipulation. Androgen receptor-overexpressing organoids showed increased epithelial AR and PSA expression and proliferation. Single-cell transcriptomics, together with qPCR and immunostaining, confirmed prostate lineage specification and tissue organization. This new xeno-free platform provides a reproducible, scalable, and genetically tractable model to study in-vitro prostate lineage programs, epithelial-stromal interactions, and disease biology. Graphic AbstractThis study describes the generation of prostate organoids from human iPSCs. iPSCs, including those reprogrammed from patients carrying germline mutations, can be differentiated into prostate organoids either through monoculture or by co-culturing endodermal cells with mesenchymal progenitors. Genetic manipulation can be introduced before endoderm specification to model cancer drivers. The resulting multi-lineage organoids exhibit distinct epithelial (AR, NKX3.1, PSA, CK8/18) and stromal (VIM, -SMA) compartments, providing a versatile platform for developmental studies, disease modelling, drug screening, and biomarker discovery. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=120 SRC="FIGDIR/small/683654v1_ufig1.gif" ALT="Figure 1"> View larger version (39K): org.highwire.dtl.DTLVardef@1cc13eborg.highwire.dtl.DTLVardef@12fe2a4org.highwire.dtl.DTLVardef@c89d64org.highwire.dtl.DTLVardef@d541e0_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: organoid / primary culture
- research focus: development & morphogenesis
- research focus: cancer & tumor microenvironment
- research focus: cell type annotation
- approach: experimental assay
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 1th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- High-throughput propagation of human prostate tissue from induced-pluripotent stem cells
Anastasia C. Hepburn, Emma L. Curry, … Rakesh Heer·Stem Cells Translational MedicinePeer-reviewed·Mar 14, 2020
- Human iPSC-derived prostate organoids with germline BRCA2 mutation undergo tumorigenic transformations
Bipul R. Acharya, George M. Lawless, … Clive N. Svendsen·bioRxiv·Aug 26, 2025
- A Novel Organoid Model of In Vitro Spermatogenesis Using Human Induced Pluripotent Stem Cells
M. A. Robinson, L. Witherspoon, … R. Flannigan·bioRxiv·Jun 4, 2021
- A modular patient-derived organoid-xenograft platform reveals molecular and clinical trajectories of prostate cancer progression
Romuald Parmentier, Robin Dolgos, … Clémentine Le Magnen·bioRxiv·Jan 5, 2026
- Generation of spermatogonia from pluripotent stem cells in humans and non-human primates
Eoin Christopher Whelan, Mingyue Guo, … Kotaro Sasaki·Cell stem cellPeer-reviewed·Jul 10, 2026
- ECM-free patient-derived organoids preserve diverse prostate cancer lineages and uncover in vitro-enriched cell types
Robin Dolgos, Romuald Parmentier, … Clémentine Le Magnen·Cell ReportsPeer-reviewed·Oct 1, 2025